12 August 2015 - CADTH has received notice of a pending submission from Apotex for Grastofil (filgrastim) for the prevention or treatment of neutropenia in various indications. For information about the patient input process or for additional instructions, please see the patient input page of the CADTH website.

For more details, go to: https://www.cadth.ca/filgrastim